CTOs on the Move

Innovative Medical Device Solutions (IMDS)

www.imds.net

 
IMDS (Innovative Medical Device Solutions) provides comprehensive product development and supply chain management solutions for medical device companies, with a focus on the orthopedic industry. IMDS is the integration of the following companies: Leis
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.imds.net
  • 13600 Heritage Pkwy Ste 170
    Fort Worth, TX USA 76177
  • Phone: 877.583.0677

Executives

Name Title Contact Details

Similar Companies

TimelyMD

Focused on improving the health of student populations, TimelyMD offers universities and colleges a comprehensive, custom program centered around telehealth. TimelyMD`s campus-wide solution gives students one point of contact--anytime, anywhere--to get quality care and immediate treatment for medical or mental health concerns from board certified physicians and licensed counselors. TimelyMD`s telehealth programs optimize clinic resources and support clinic staff in delivering quality care to the right students at the right times.

Open Door Health Center

Open Door Health Center is a Homestead, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bryan Health

Bryan Health is a not-for-profit healthcare system with two acute care facilities in Lincoln, a critical access hospital in Crete, outpatient clinics, and a statewide network that provides sophisticated mobile diagnostic treatment and services to citiz...

SCR Medical Transportation

SCR Medical Transportation is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aratana Terapeutics

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.